+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 1k8r | ||||||
---|---|---|---|---|---|---|---|
タイトル | Crystal structure of Ras-Bry2RBD complex | ||||||
要素 |
| ||||||
キーワード | SIGNALING PROTEIN / signal transduction / cancer / GTPase / ubiquitin fold | ||||||
機能・相同性 | 機能・相同性情報 Oxidative Stress Induced Senescence / induction of conjugation with cellular fusion / pheromone response MAPK cascade / division septum / cell tip / mitogen-activated protein kinase kinase kinase / phospholipase C activator activity / GTPase complex / oncogene-induced cell senescence / positive regulation of ruffle assembly ...Oxidative Stress Induced Senescence / induction of conjugation with cellular fusion / pheromone response MAPK cascade / division septum / cell tip / mitogen-activated protein kinase kinase kinase / phospholipase C activator activity / GTPase complex / oncogene-induced cell senescence / positive regulation of ruffle assembly / negative regulation of GTPase activity / regulation of neurotransmitter receptor localization to postsynaptic specialization membrane / positive regulation of miRNA metabolic process / T-helper 1 type immune response / positive regulation of wound healing / cell division site / defense response to protozoan / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / RAS signaling downstream of NF1 loss-of-function variants / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / MAP kinase kinase kinase activity / SHC1 events in ERBB4 signaling / positive regulation of protein targeting to membrane / Signalling to RAS / SHC-related events triggered by IGF1R / Activated NTRK2 signals through FRS2 and FRS3 / adipose tissue development / SHC-mediated cascade:FGFR2 / Estrogen-stimulated signaling through PRKCZ / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / Schwann cell development / SHC-mediated cascade:FGFR4 / Signaling by FGFR4 in disease / Erythropoietin activates RAS / SHC-mediated cascade:FGFR1 / FRS-mediated FGFR2 signaling / protein-membrane adaptor activity / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / Signaling by FGFR2 in disease / FRS-mediated FGFR4 signaling / p38MAPK events / Signaling by FGFR3 in disease / Tie2 Signaling / FRS-mediated FGFR1 signaling / GRB2 events in EGFR signaling / FLT3 Signaling / SHC1 events in EGFR signaling / EGFR Transactivation by Gastrin / Signaling by FLT3 fusion proteins / EPHB-mediated forward signaling / Signaling by FGFR1 in disease / myelination / Ras activation upon Ca2+ influx through NMDA receptor / GRB2 events in ERBB2 signaling / intrinsic apoptotic signaling pathway / CD209 (DC-SIGN) signaling / NCAM signaling for neurite out-growth / SHC1 events in ERBB2 signaling / Downstream signal transduction / Constitutive Signaling by Overexpressed ERBB2 / Insulin receptor signalling cascade / positive regulation of epithelial cell proliferation / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / positive regulation of GTPase activity / small monomeric GTPase / VEGFR2 mediated cell proliferation / G protein activity / regulation of actin cytoskeleton organization / animal organ morphogenesis / FCERI mediated MAPK activation / positive regulation of JNK cascade / Signaling by ERBB2 TMD/JMD mutants / RAF activation / positive regulation of MAP kinase activity / Signaling by high-kinase activity BRAF mutants / regulation of long-term neuronal synaptic plasticity / Constitutive Signaling by EGFRvIII / MAP2K and MAPK activation / Signaling by ERBB2 ECD mutants / Signaling by SCF-KIT / Signaling by ERBB2 KD Mutants / cellular response to gamma radiation / positive regulation of type II interferon production / Regulation of RAS by GAPs / endocytosis / RAS processing / Negative regulation of MAPK pathway / Signaling by RAF1 mutants / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants 類似検索 - 分子機能 | ||||||
生物種 | Homo sapiens (ヒト) Schizosaccharomyces pombe (分裂酵母) | ||||||
手法 | X線回折 / 分子置換 / 解像度: 3 Å | ||||||
データ登録者 | Scheffzek, K. / Gruenewald, P. / Wohlgemuth, S. / Kabsch, W. / Tu, H. / Wigler, M. / Wittinghofer, A. / Herrmann, C. | ||||||
引用 | ジャーナル: Structure / 年: 2001 タイトル: The Ras-Byr2RBD complex: structural basis for Ras effector recognition in yeast. 著者: Scheffzek, K. / Grunewald, P. / Wohlgemuth, S. / Kabsch, W. / Tu, H. / Wigler, M. / Wittinghofer, A. / Herrmann, C. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 1k8r.cif.gz | 65.1 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb1k8r.ent.gz | 47.3 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 1k8r.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 1k8r_validation.pdf.gz | 756.3 KB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 1k8r_full_validation.pdf.gz | 761.7 KB | 表示 | |
XML形式データ | 1k8r_validation.xml.gz | 8.9 KB | 表示 | |
CIF形式データ | 1k8r_validation.cif.gz | 11.6 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/k8/1k8r ftp://data.pdbj.org/pub/pdb/validation_reports/k8/1k8r | HTTPS FTP |
-関連構造データ
関連構造データ | 5p21S S: 精密化の開始モデル |
---|---|
類似構造データ |
-リンク
-集合体
登録構造単位 |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
|
-要素
#1: タンパク質 | 分子量: 18875.191 Da / 分子数: 1 / 断片: GTP-binding/catalytic domain, residues 1-166 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: Hras or Hras1 / プラスミド: pGEX-2T / 発現宿主: Escherichia coli (大腸菌) / 株 (発現宿主): CK600K / 参照: UniProt: P01112 |
---|---|
#2: タンパク質 | 分子量: 12426.270 Da / 分子数: 1 / 断片: Ras binding domain (RBD), residues 71-180 / 由来タイプ: 組換発現 由来: (組換発現) Schizosaccharomyces pombe (分裂酵母) 遺伝子: BYR2 or STE8 or SPBC1D7.05 / プラスミド: pGEX-2T / 生物種 (発現宿主): Escherichia coli / 発現宿主: Escherichia coli BL21 (大腸菌) / 株 (発現宿主): BL21 参照: UniProt: P28829, 転移酵素; リンを含む基を移すもの; キナーゼ(アルコールにつなげるもの) |
#3: 化合物 | ChemComp-MG / |
#4: 化合物 | ChemComp-GNP / |
-実験情報
-実験
実験 | 手法: X線回折 / 使用した結晶の数: 4 |
---|
-試料調製
結晶 | マシュー密度: 3.35 Å3/Da / 溶媒含有率: 63.29 % | |||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | 温度: 290 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 8 詳細: PEG 3350, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 290K | |||||||||||||||||||||||||||||||||||
結晶化 | *PLUS | |||||||||||||||||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
回折 | 平均測定温度: 290 K |
---|---|
放射光源 | 由来: 回転陽極 / タイプ: ELLIOTT GX-18 / 波長: 1.54 Å |
検出器 | タイプ: SIEMENS-NICOLET / 検出器: AREA DETECTOR / 日付: 1996年8月6日 / 詳細: mirrors |
放射 | モノクロメーター: Ni Mirror / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.54 Å / 相対比: 1 |
反射 | 解像度: 3→25 Å / Num. all: 8592 / Num. obs: 8526 / % possible obs: 99.7 % / Observed criterion σ(F): 0 / Observed criterion σ(I): -3 / 冗長度: 12.8 % / Biso Wilson estimate: 56 Å2 / Rmerge(I) obs: 0.139 / Rsym value: 0.139 / Net I/σ(I): 18.6 |
反射 シェル | 解像度: 3→3.1 Å / 冗長度: 3.3 % / Rmerge(I) obs: 0.3 / Mean I/σ(I) obs: 4.1 / Num. unique all: 788 / Rsym value: 0.3 / % possible all: 99.9 |
反射 | *PLUS 最高解像度: 3 Å / 最低解像度: 25 Å / Num. measured all: 109981 |
反射 シェル | *PLUS 最高解像度: 3 Å / % possible obs: 100 % / Num. unique obs: 788 / Num. measured obs: 2634 / Rmerge(I) obs: 0.305 |
-解析
ソフトウェア |
| |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: 分子置換 開始モデル: PDB entry 5p21 解像度: 3→25 Å / Rfactor Rfree error details: 0.01 / Isotropic thermal model: isotropic / 交差検証法: THROUGHOUT / σ(F): 0 / 立体化学のターゲット値: Engh & Huber 詳細: residues 127-139 and 166-180 of Byr2 are ill defined in electron density and are not included in the model
| |||||||||||||||||||||||||
Refine analyze |
| |||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 3→25 Å
| |||||||||||||||||||||||||
拘束条件 |
| |||||||||||||||||||||||||
LS精密化 シェル | 解像度: 3→3.19 Å / Rfactor Rfree error: 0.029 / Total num. of bins used: 6
| |||||||||||||||||||||||||
精密化 | *PLUS 最高解像度: 3 Å / 最低解像度: 25 Å / σ(F): 0 / % reflection Rfree: 10 % / Rfactor obs: 0.236 / Rfactor Rfree: 0.312 | |||||||||||||||||||||||||
溶媒の処理 | *PLUS | |||||||||||||||||||||||||
原子変位パラメータ | *PLUS | |||||||||||||||||||||||||
拘束条件 | *PLUS
| |||||||||||||||||||||||||
LS精密化 シェル | *PLUS 最高解像度: 3 Å / Rfactor Rfree: 0.35 / % reflection Rfree: 10.3 % / Rfactor Rwork: 0.297 |